Analysts who follow HTG Molecular Diagnostics Inc (HTGM) on average expect it to climb 217.07% over the next twelve months. Those same analysts give the stock an average rating of Strong Buy.
That average rating earns the stock an Analyst Ranking of 67, which means it ranks higher than 67 of stocks, based on data compiled by InvestorsObserver.
Why are Analyst Ratings Important?
Analysts know the inner workings of the companies they follow better than anyone but the companies’ management. You can learn a lot about a company from studying the financial statements, but analysts ask questions on conference calls and understand the intricacies of each of the businesses they cover. Analysts understand how bad weather in one part of the world can disrupt supply chains, or disrupt shopping patterns. This lets traders make decisions before a quarterly report that could be worse than expected.
InvestorsObserver aggregates the ratings of all the analysts covering a given stock, takes the average of those ratings and then percentile ranks the averages. That provides a level of granularity that is significantly better than just the three levels provided by traditional buy/hold/sell ratings.
What's Happening With HTG Molecular Diagnostics Inc Stock Today?
HTG Molecular Diagnostics Inc (HTGM) stock is trading at $5.32 as of 10:47 AM on Friday, Dec 4, a gain of $0.23, or 4.52% from the previous closing price of $5.09. The stock has traded between $5.16 and $5.48 so far today. Volume today is low. So far 75,361 shares have traded compared to average volume of 215,394 shares.